1 Min Read
Feb 7 (Reuters) - Aldeyra Therapeutics Inc
* Aldeyra therapeutics announces first patient enrolled in allergic conjunctivitis phase 2b clinical trial Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.